EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Detecting Misfolded α‐Synuclein in Blood Years before the Diagnosis of Parkinson's Disease

Annika Kluge iD, Eva Schaeffer iD, Josina Bunk, Michael Sommerauer, Sinah Röttgen iD, Claudia Schulte iD, Benjamin Roeben iD, Anna-Katharina von Thaler, Julius Welzel, Ralph Lucius, Sebastian Heinzel, Wei Xiang und 4 weitere

Movement Disorders · 2024-08 · 39 (8) · 1289-1299

DOI: 10.1002/mds.29766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 23.04.2024. Verfasst von Annika Kluge und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital Kiel, Christian-Albrechts-University Kiel, Kiel, Germany. Hauptthemen laut MEDLINE: Parkinson Disease, alpha-Synuclein, Prodromal Symptoms, Biomarkers. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Identifying individuals with Parkinson's disease (PD) already in the prodromal phase of the disease has become a priority objective for opening a window for early disease‐modifying therapies.

Objective

The aim was to evaluate a blood‐based α‐synuclein seed amplification assay (α‐syn SAA) as a novel biomarker for diagnosing PD in the prodromal phase.

Methods

In the TREND study (University of Tuebingen) biennial blood samples of n = 1201 individuals with/without increased risk for PD were taken prospectively over 4 to 10 years. We retrospectively analyzed blood samples of 12 participants later diagnosed with PD during the study to detect and amplify pathological α‐syn conformers derived from neuronal extracellular vesicles using (1) immunoblot analyses with an antibody against these conformers and (2) an α‐syn‐SAA. Additionally, blood samples of n = 13 healthy individuals from the TREND cohort and n = 20 individuals with isolated rapid eye movement sleep behavior disorder (iRBD) from the University Hospital Cologne were analyzed.

Results

All individuals with PD showed positive immunoblots and a positive α‐syn SAA at the time of diagnosis. Moreover, all PD patients showed a positive α‐syn SAA 1 to 10 years before clinical diagnosis. In the iRBD cohort, 30% showed a positive α‐syn SAA. All healthy controls had a negative SAA.

Conclusions

We here demonstrate the possibility to detect and amplify pathological α‐syn conformers in peripheral blood up to 10 years before the clinical diagnosis of PD in individuals with and without iRBD. The findings of this study indicate that this blood‐based α‐syn SAA assay has the potential to serve as a diagnostic biomarker for prodromal PD. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson Diseasealpha-SynucleinProdromal SymptomsBiomarkersHumansFemaleMaleAgedMiddle AgedREM Sleep Behavior DisorderRetrospective Studies

Stichwörter der Autor:innen

Parkinson's diseasebiomarkerneuron‐derived extracellular vesiclesseed amplification assayα‐synuclein

Substanzen

alpha-SynucleinBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, University Hospital Kiel, Christian-Albrechts-University Kiel, Kiel, Germany.
  • Department of Neurology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Centre Jülich, Jülich, Germany.
  • Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
  • German Center for Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany.
  • Institute of Anatomy, Kiel University, Kiel, Germany.

ORCID-Profile: Annika Kluge, Eva Schaeffer, Sinah Röttgen, Claudia Schulte, Benjamin Roeben

Zitieren

APA

Kluge, A., Schaeffer, E., Bunk, J., Sommerauer, M., Röttgen, S., Schulte, C., Roeben, B., von Thaler, A. K., Welzel, J., Lucius, R., Heinzel, S., Xiang, W., Eschweiler, G. W., Maetzler, W., Suenkel, U., & Berg, D. (2024). Detecting Misfolded α‐Synuclein in Blood Years before the Diagnosis of Parkinson's Disease. Movement Disorders, 39(8), 1289-1299. https://doi.org/10.1002/mds.29766

Vancouver

Kluge A, Schaeffer E, Bunk J, Sommerauer M, Röttgen S, Schulte C, et al. Detecting Misfolded α‐Synuclein in Blood Years before the Diagnosis of Parkinson's Disease. Movement Disorders. 2024;39(8):1289-1299. doi:10.1002/mds.29766

BibTeX
@article{Kluge2024,
  author = {Kluge, Annika and Schaeffer, Eva and Bunk, Josina and Sommerauer, Michael and Röttgen, Sinah and Schulte, Claudia and Roeben, Benjamin and von Thaler, Anna-Katharina and Welzel, Julius and Lucius, Ralph and Heinzel, Sebastian and Xiang, Wei and Eschweiler, Gerhard W and Maetzler, Walter and Suenkel, Ulrike and Berg, Daniela},
  title = {Detecting Misfolded α‐Synuclein in Blood Years before the Diagnosis of Parkinson's Disease},
  journal = {Movement Disorders},
  year = {2024},
  volume = {39},
  number = {8},
  pages = {1289--1299},
  doi = {10.1002/mds.29766}
}
Kostenlos starten →